Nanopore Method for Identifying Single Amino Acid in Oligopeptides

    公开(公告)号:US20210372959A1

    公开(公告)日:2021-12-02

    申请号:US17212021

    申请日:2021-03-25

    发明人: Chang Liu Qian Wang

    IPC分类号: G01N27/12 G01N33/68

    摘要: The current disclosure provides a transformative concept based on nanopore technology, Sequencing-by-Hydrolysis, to identify the N-terminal amino acid and the length of each peptide fragment in a peptide ladder to reconstitute the sequence of a protein: a protein/peptide analyte will be nonspecifically hydrolyzed to generate random fragments of the analyte that are different by one amino acid with the N-terminal amino acid of each fragment modified so it generates a distinguishable fingerprint signal when tested by nanopore. The length of the fragment can be estimated by characterizing its translocation signal to back calculate the location of the amino acid in the original analyte. This approach will significantly advance the nanopore technology with single amino acid resolution for protein/peptide sequencing.

    Bionanomaterials and Their Synthesis
    3.
    发明申请

    公开(公告)号:US20170096643A9

    公开(公告)日:2017-04-06

    申请号:US13685122

    申请日:2012-11-26

    IPC分类号: C12N7/00

    摘要: The use of biomaterials, such as viruses and virus-like particles, to form nanostructures is generally disclosed. For instance, rod-like viruses can be used to form composite nanofibers that are fixed together in a head-to-tail assembly by a polymer. Also, 2-dimensional nanostructures formed from crosslinked viruses assembled in a single, film-like layer are generally disclosed. Porous gels having controllable pore size through the use of virus particles are also disclosed.

    M13 bacteriophage as a chemoaddressable nanoparticle for biological and medical applications
    4.
    发明授权
    M13 bacteriophage as a chemoaddressable nanoparticle for biological and medical applications 有权
    M13噬菌体作为用于生物和医学应用的化学可接地纳米颗粒

    公开(公告)号:US09551666B2

    公开(公告)日:2017-01-24

    申请号:US13800526

    申请日:2013-03-13

    IPC分类号: C12Q1/70 G01N21/64 C12N7/00

    摘要: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.

    摘要翻译: 通常提供活性和改良的M13噬菌体及其制备和使用方法。 反应性M13噬菌体可以包括共价连接到M13噬菌体上的炔官能团。 修饰的M13噬菌体可以包括通过1,2,3-三唑键共价连接到M13噬菌体上的取代基。 也通常提供双重修饰的M13噬菌体,并且可以包括共价连接到M13噬菌体的癌靶向取代基和共价连接到M13噬菌体的荧光基团。 修饰的M13噬菌体不仅可以用作癌症成像的荧光探针,还可以用作细胞比对和脚手架的生物材料。

    M13 Bacteriophage as a Chemoaddressable Nanoparticle for Biological and Medical Applications
    5.
    发明申请
    M13 Bacteriophage as a Chemoaddressable Nanoparticle for Biological and Medical Applications 有权
    M13噬菌体作为生物和医学应用的化学可接地纳米粒子

    公开(公告)号:US20130337435A1

    公开(公告)日:2013-12-19

    申请号:US13800526

    申请日:2013-03-13

    IPC分类号: G01N21/64

    摘要: Reactive and modified M13 bacteriophages, and methods of making and using the same, are generally provided. The reactive M13 bacteriophage can include a alkyne functional group covalently attached to the M13 bacteriophage. The modified M13 bacteriophage can include a substituent covalently attached to the M13 bacteriophage via a 1,2,3-triazole linkage. Dual-modified M13 bacteriophages are also generally provided, and can include a cancer-targeting substituent covalently attached to the M13 bacteriophage and a fluorescent group covalently attached to the M13 bacteriophage. The modified M13 bacteriophages can not only be employed as a fluorescent probe for cancer imaging, but also can be used as biomaterials for cell alignment and scaffolding.

    摘要翻译: 通常提供活性和改良的M13噬菌体及其制备和使用方法。 反应性M13噬菌体可以包括共价连接到M13噬菌体上的炔官能团。 修饰的M13噬菌体可以包括通过1,2,3-三唑键共价连接到M13噬菌体上的取代基。 也通常提供双重修饰的M13噬菌体,并且可以包括共价连接到M13噬菌体的癌靶向取代基和共价连接到M13噬菌体的荧光基团。 修饰的M13噬菌体不仅可以用作癌症成像的荧光探针,还可以用作细胞比对和脚手架的生物材料。

    Bionanomaterials and Their Synthesis
    6.
    发明申请
    Bionanomaterials and Their Synthesis 审中-公开
    Bionan材料及其合成

    公开(公告)号:US20130143303A1

    公开(公告)日:2013-06-06

    申请号:US13685122

    申请日:2012-11-26

    IPC分类号: C12N7/00

    摘要: The use of biomaterials, such as viruses and virus-like particles, to form nanostructures is generally disclosed. For instance, rod-like viruses can be used to form composite nanofibers that are fixed together in a head-to-tail assembly by a polymer. Also, 2-dimensional nanostructures formed from crosslinked viruses assembled in a single, film-like layer are generally disclosed. Porous gels having controllable pore size through the use of virus particles are also disclosed.

    摘要翻译: 通常公开了使用诸如病毒和病毒样颗粒的生物材料来形成纳米结构。 例如,棒状病毒可以用于形成复合纳米纤维,它们通过聚合物以头对尾组装方式固定在一起。 此外,通常公开了由组装在单个膜状层中的交联病毒形成的二维纳米结构。 还公开了通过使用病毒颗粒具有可控孔径的多孔凝胶。